GLYCOMIMETICS
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
GLYCOMIMETICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2003-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.glycomimetics.com
Total Employee:
51+
Status:
Active
Contact:
2402431207
Email Addresses:
[email protected]
Total Funding:
194.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Ampio Pharmaceuticals
Ampio Pharmaceuticals is a biopharmaceutical firm that discovers and develops novel therapies for treating inflammatory conditions.
Calithera Biosciences
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Epirium Bio
Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.
Cascadian Therapeutics
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Innovation Pharmaceuticals
Innovation Pharmaceuticals is a biopharmaceutical company developing small molecule therapies in areas of unmet medical needs.
Celsion
Celsion is a biopharmaceutical company which develops innovative, targeted therapies that address unmet medical needs in oncology.
Celtaxsys
Celtaxsys is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.
Cequent Pharmaceuticals
Cequent is a biopharmaceutical company pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases.
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals develops small molecule therapeutics for treating life-threatening medical conditions.
Immunomedics
Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Molecular Templates
Molecular Templates develops novel therapeutic compounds for cancer.
Palatin Technologies
Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.
Phoenix Molecular Designs
Phoenix Molecular Designs is a biopharmaceutical company designing precise cancer therapeutics by targeting kinases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Sequoia Sciences
Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
TesoRx Pharma
TesoRx is a virtual pharmaceutical company developing and commercializing pharmaceutical products.
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series C - GlycoMimetics
Sanofi Ventures
Sanofi Ventures investment in Series C - GlycoMimetics
New Enterprise Associates
New Enterprise Associates investment in Series C - GlycoMimetics
Alliance Technology Ventures
Alliance Technology Ventures investment in Series C - GlycoMimetics
Anthem Capital Management
Anthem Capital Management investment in Series C - GlycoMimetics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - GlycoMimetics
Anthem Capital Management
Anthem Capital Management investment in Series B - GlycoMimetics
PTV Healthcare Capital
PTV Healthcare Capital investment in Series B - GlycoMimetics
Alliance Technology Ventures
Alliance Technology Ventures investment in Series B - GlycoMimetics
New Enterprise Associates
New Enterprise Associates investment in Series B - GlycoMimetics
Key Employee Changes
Official Site Inspections
http://www.glycomimetics.com Semrush global rank: 9.87 M Semrush visits lastest month: 93
- Host name: mi3-ts2.a2hosting.com
- IP address: 70.32.23.55
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "GlycoMimetics"
About Us - Glycomimetics
Jul 25, 2024 GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases. Our leading researchers leverage their deep …See details»
GlycoMimetics - Crunchbase Company Profile
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic …See details»
GlycoMimetics, Inc. (GLYC) Company Profile & Facts - Yahoo Finance
See the company profile for GlycoMimetics, Inc. (GLYC) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Board of Directors | GlycoMimetics, Inc.
Nov 6, 2024 GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint. July 25, 2024 GlycoMimetics Announces …See details»
GlycoMimetics Company Profile: Overview and Full News Analysis
GlycoMimetics is a late clinical-stage biotechnology company based in Maryland, specializing in discovering and developing glycobiology-based therapies for cancers and inflammatory …See details»
GlycoMimetics, Inc. Company Profile | Rockville, MD | Competitors ...
Company Description: Carbs are a good thing to GlycoMimetics. The biotechnology company uses carbohydrate chemistry to develop drug candidates for rare diseases. Its lead drug …See details»
GlycoMimetics - LinkedIn
GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies. GlycoMimetics | 4,138 followers on LinkedIn. At GlycoMimetics, …See details»
GlycoMimetics - Overview, News & Similar companies - ZoomInfo
May 19, 2024 Who is GlycoMimetics. GlycoMimetics, Inc., a clinical stage biotechnology company, focuses on the discovery and development of glycomimetic drugs to address unmet …See details»
GlycoMimetics, Inc. (GLYC) Company Profile & Facts - Yahoo Finance
GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. It develops uproleselan, …See details»
GlycoMimetics - Funding, Financials, Valuation & Investors
GlycoMimetics is registered under the ticker NASDAQ:GLYC . Their stock opened with $8.00 in its Jan 10, 2014 IPO. GlycoMimetics is funded by 8 investors. Cowen Investment Management …See details»
GlycoMimetics - Contacts, Employees, Board Members, Advisors
Organization. GlycoMimetics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 13. Number of …See details»
GlycoMimetics Announces Strategic Review and Corporate …
ROCKVILLE, Md., July 25, 2024--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers …See details»
GlycoMimetics Company Profile 2025: Stock Performance
Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of …See details»
Careers - Glycomimetics
GlycoMimetics is a great place to work. When you join our organization, you will be part of a team that is committed to making a difference in the lives of people living with sickle cell disease, …See details»
GlycoMimetics Company Profile - Craft
Oct 29, 2024 GlycoMimetics is a clinical-stage biotechnology company. The Company uses novel and proprietary glycobiology technology to develop treatments for diseases, particularly …See details»
GlycoMimetics Inc, GLYC:NAQ profile - FT.com - Financial Times
6 days ago It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions …See details»
Collaborations - Glycomimetics
In May 2021, GlycoMimetics announced that clinicians at Washington University School of Medicine in St. Louis dosed the first patient in an investigator-sponsored trial (IST) evaluating …See details»
GlycoMimetics, Inc. (GLYC): A New Era on the Horizon with …
Oct 29, 2024 With the acquisition, GlycoMimetics will take on Crescent’s existing and future assets, creating a portfolio centered around CR-001—a tetravalent PD-1 x VEGF bispecific …See details»
Understanding Glycobiology - Glycomimetics
Jul 25, 2024 GlycoMimetics, Inc. has recognized the importance of carbohydrate interactions in different diseases, including cancer, and have become pioneers in the development of drugs …See details»